Clinical Trial Detail

NCT ID NCT02859857
Title Phase 1 Study of BXQ-350 in Adult Patients With Advanced Solid Tumors
Recruitment Active, not recruiting
Gender both
Phase Phase I
Variant Requirements No
Sponsors Bexion Pharmaceuticals, LLC.
Indications

malignant glioma

Advanced Solid Tumor

Therapies

BXQ-350

Age Groups: adult senior

No variant requirements are available.